Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. (Q53230710)

12 May 2018

title

Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. (English)

1 reference

12 May 2018

author name string

Zagorski MG

1

1 reference

12 May 2018

Yang J

2

1 reference

12 May 2018

Shao H

3

1 reference

12 May 2018

Ma K

4

1 reference

12 May 2018

Zeng H

5

1 reference

12 May 2018

Hong A

6

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

12 May 2018

published in

Methods in Enzymology

1 reference

12 May 2018

volume

309

1 reference

12 May 2018

page(s)

189-204

1 reference

12 May 2018

The toxicity in vitro of beta-amyloid protein

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Solvent effects on self-assembly of beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

pH-dependent structural transitions of Alzheimer amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Mass spectrometry of macromolecules: has its time now come?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Methodological variables in the assessment of beta amyloid neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Alzheimer's beta-amyloid peptide: affinity for metal chelates.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Nicotine inhibits amyloid formation by the beta-peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

Determination of D- and L-aspartate in amino acid mixtures by high-performance liquid chromatography after derivatization with a chiral adduct of o-phthaldialdehyde

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

All-D-enantiomers of beta-amyloid exhibit similar biological properties to all-L-beta-amyloids.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2909015-1

7 January 2021

10.1016/S0076-6879(99)09015-1

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

10507025

1 reference

12 May 2018